No. As of May 2025, hospitals in Malaysia are no longer permitted to keep medicine prices hidden. A mandatory price display requirement now applies to all licensed pharmacies and private hospitals — patients have the right to see what medicines cost before or during their treatment, not just when the final bill arrives. This was one of the most significant consumer protection changes in Malaysian healthcare in recent years, targeting one of the biggest and least visible drivers of private hospital bills.
What Changed in May 2025
Before the May 2025 requirement, a patient admitted to a private hospital had virtually no visibility into what individual medicines were costing. The total bill would appear at discharge, and medicine charges were typically lumped together or itemised in a way that was difficult to cross-reference against any external price.
The new mandatory display requirement changes this in a specific way: every licensed pharmacy and every private hospital must now display the prices of medicines they dispense or administer. The intent is that a patient — or their family member acting on their behalf — can ask to see the medicine price list before those medicines are administered, or at minimum can check the bill line by line against the displayed prices.
This applies to the same medicines whether they are dispensed at a retail pharmacy or administered during a hospital stay. The enforcement mechanism is through the licensing and inspection regime for healthcare facilities under the Ministry of Health.
Why Medicine Prices in Private Hospitals Have Been Such a Problem
Medicine is not a minor line item on a private hospital bill. For many admissions, it represents 30–50% of the total charge. And the markup structure in private hospitals has historically been very different from what you would pay at a pharmacy.
A branded medication available at a retail pharmacy for RM 20 per tablet can appear on a private hospital bill at RM 80–120 per tablet — a 400–600% markup. This is not fraud; it reflects hospitals’ cost structures including storage, handling, wastage, and staffing of the hospital pharmacy. But patients had no way to know this was happening or how their hospital compared to others.
In the absence of price transparency, there was no market pressure to constrain medicine pricing at the hospital level. The May 2025 requirement introduces at least a baseline of accountability: if prices must be displayed, outliers become visible.
The January 2026 Reference Guide on Price Ranges for Common Private Healthcare Services (published by LIAM and PIAM) complements this by providing benchmarks for procedure costs — so both the procedural and medicine components of a bill now have some external reference point.
How to Actually Use the Price Transparency Rules
The rules exist, but exercising them requires knowing what to ask for. Most patients do not spontaneously receive a medicine price list — they need to request it.
For planned admissions:
- Before your admission date, ask the hospital’s pharmacy or billing department to provide the price list for the medicines likely to be used in your treatment plan. Your surgeon or specialist can give you a general list of what your procedure typically requires.
- Compare those prices against what the same medicines cost at a community pharmacy if you can find a comparator. The difference will tell you what the hospital’s margin looks like.
- For very expensive branded drugs — cancer drugs, biologic therapies, specialist cardiac medicines — it is worth asking whether a generic equivalent is available and whether it is medically appropriate for your situation.
After admission, during bill review:
- Request a fully itemised bill. Do not accept a summary. Every medicine administered should appear as a separate line.
- Ask to see the hospital’s medicine price list and verify that each line item matches the displayed price.
- If any medicine on your bill is priced above the displayed price list, flag it in writing before paying. This is now a compliance issue, not just a billing dispute.
If you hold a medical card plan, forward any discrepancies to your insurer. Insurers conduct their own bill audits, but they benefit from knowing which specific lines you have identified as potentially mispriced.
What the Revamp of Hospital Billing Structures Will Add
The medicine price transparency requirement is one part of a broader push toward hospital billing reform in Malaysia. The government has also flagged an upcoming revamp of hospital billing structures to ensure that charges are cost-reflective, fair, and transparent across all components of a hospital bill — not just medicines.
The current timeline for this revamp has not been finalised as of mid-2026. But the direction is clear: the era of opaque, take-it-or-leave-it hospital billing is ending. The combination of mandatory medicine price display, the 2026 procedure price reference guide, and the forthcoming billing structure reform represents a coordinated shift toward greater accountability in private healthcare pricing.
For patients, this means increasingly having the information needed to be an active participant in understanding and, where appropriate, contesting their hospital bills.
Frequently Asked Questions
Can I request medicine prices before I agree to treatment at a private hospital?
Yes. Since May 2025, hospitals must display medicine prices, which means you can request a price list before medicines are administered for planned procedures. In practice, bring this up when confirming your admission with the hospital’s billing or pharmacy team. For emergency admissions, this is harder to exercise in the moment — but it applies during the post-discharge bill review.
What if the hospital’s medicine charges on my bill do not match their displayed price list?
This is a compliance issue under the mandatory display requirement. You should flag it in writing to the hospital’s billing department and request a correction before settling the bill. If the discrepancy is unresolved, you can escalate to the Ministry of Health or, if you have medical insurance, ask your insurer to intervene during the claims process.
Does the mandatory price display requirement cover all medicines, including expensive cancer drugs?
The requirement applies to medicines dispensed or administered by licensed pharmacies and private hospitals. This includes specialist drugs and biologics. High-cost medicines are precisely where price transparency matters most, since a single course of a targeted cancer therapy can run RM 20,000–80,000.
Are there limits on how much private hospitals can mark up medicines?
Not currently. The mandatory display requirement creates transparency but does not cap markups. The forthcoming revamp of hospital billing structures may introduce cost-reflective pricing guidelines, but no markup limits are in place as of mid-2026. Your best protection is to ask about drug costs in advance for planned treatments and to check whether your medical card plan covers the specific drugs in your treatment protocol.
How does this relate to my medical insurance?
Medical card plans typically cover medicines administered during a covered hospitalisation, subject to annual limits and any sub-limits on your plan. If a hospital overcharges for medicines, your insurer may negotiate the bill down during the claims process — which can affect whether the full amount is reimbursed. Understanding what medicines cost, and flagging discrepancies, helps both you and your insurer ensure the bill is accurate before the claim is settled.
Have a question that wasn’t covered here? Our advisors at FINNO. offer free, no-obligation consultations — no hard sell, just honest answers about what’s right for your situation.